Henry Schein, Inc. (HSIC) Shares Bought by Aperio Group LLC
Aperio Group LLC increased its position in Henry Schein, Inc. (NASDAQ:HSIC) by 99.1% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 89,954 shares of the company’s stock after buying an additional 44,765 shares during the quarter. Aperio Group LLC owned about 0.06% of Henry Schein worth $7,375,000 at the end of the most recent reporting period.
Several other institutional investors have also recently made changes to their positions in the company. Eads & Heald Investment Counsel lifted its holdings in shares of Henry Schein by 0.5% in the second quarter. Eads & Heald Investment Counsel now owns 1,497 shares of the company’s stock valued at $274,000 after buying an additional 8 shares during the period. Intrust Bank NA lifted its holdings in shares of Henry Schein by 1.1% during the second quarter. Intrust Bank NA now owns 1,219 shares of the company’s stock valued at $223,000 after purchasing an additional 13 shares during the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its position in Henry Schein by 0.3% during the second quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 5,894 shares of the company’s stock valued at $1,079,000 after buying an additional 19 shares during the period. YorkBridge Wealth Partners LLC raised its position in Henry Schein by 5.2% during the second quarter. YorkBridge Wealth Partners LLC now owns 570 shares of the company’s stock valued at $104,000 after buying an additional 28 shares during the period. Finally, Sawtooth Solutions LLC raised its position in Henry Schein by 2.4% during the second quarter. Sawtooth Solutions LLC now owns 1,347 shares of the company’s stock valued at $247,000 after buying an additional 32 shares during the period. Institutional investors and hedge funds own 47.48% of the company’s stock.
TRADEMARK VIOLATION NOTICE: “Henry Schein, Inc. (HSIC) Shares Bought by Aperio Group LLC” was first published by Watch List News and is owned by of Watch List News. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of United States & international trademark & copyright laws. The original version of this piece can be accessed at https://www.watchlistnews.com/henry-schein-inc-hsic-shares-bought-by-aperio-group-llc/1680406.html.
Several analysts have recently issued reports on the company. UBS AG reiterated a “buy” rating on shares of Henry Schein in a research note on Friday, September 15th. Northcoast Research upgraded Henry Schein from a “neutral” rating to a “buy” rating and set a $109.00 target price for the company in a research note on Monday, August 7th. Robert W. Baird set a $95.00 price objective on Henry Schein and gave the stock a “buy” rating in a research report on Thursday, October 19th. Morgan Stanley assumed coverage on Henry Schein in a report on Thursday, September 21st. They issued an “equal weight” rating and a $88.00 target price for the company. Finally, Stifel Nicolaus reaffirmed a “hold” rating and set a $89.00 price target on shares of Henry Schein in a report on Thursday, October 19th. One analyst has rated the stock with a sell rating, ten have given a hold rating and six have issued a buy rating to the stock. Henry Schein currently has a consensus rating of “Hold” and an average target price of $93.77.
Shares of Henry Schein, Inc. (NASDAQ:HSIC) opened at $77.64 on Friday. The company has a debt-to-equity ratio of 0.28, a quick ratio of 0.85 and a current ratio of 1.55. Henry Schein, Inc. has a 12 month low of $73.61 and a 12 month high of $93.50. The firm has a market capitalization of $12,275.82, a price-to-earnings ratio of 21.96, a price-to-earnings-growth ratio of 2.08 and a beta of 1.03.
Henry Schein (NASDAQ:HSIC) last released its earnings results on Tuesday, August 8th. The company reported $0.88 earnings per share for the quarter, topping the consensus estimate of $0.86 by $0.02. Henry Schein had a return on equity of 19.91% and a net margin of 4.59%. The firm had revenue of $3.06 billion during the quarter, compared to analysts’ expectations of $3.05 billion. During the same period in the prior year, the company earned $0.82 earnings per share. The company’s quarterly revenue was up 6.4% on a year-over-year basis. equities analysts anticipate that Henry Schein, Inc. will post 3.64 EPS for the current fiscal year.
Henry Schein announced that its board has authorized a share buyback plan on Monday, September 18th that authorizes the company to repurchase $400.00 million in shares. This repurchase authorization authorizes the company to repurchase up to 6.3% of its stock through open market purchases. Stock repurchase plans are usually a sign that the company’s leadership believes its stock is undervalued.
In other news, SVP Paul Rose sold 2,126 shares of the company’s stock in a transaction on Wednesday, September 6th. The shares were sold at an average price of $172.51, for a total transaction of $366,756.26. Following the completion of the transaction, the senior vice president now directly owns 17,841 shares in the company, valued at $3,077,750.91. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 1.19% of the stock is currently owned by corporate insiders.
About Henry Schein
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.